Ibnsina Pharma ISPH
ابن سينا فارما
Health Care & PharmaceuticalsEgyptian Exchange
10.33 EGP
-0.39%
Close of Thu 12 Nov 2026
- Market value
- EGP 10.28bn
- Highest and lowest close in a year
- 9.14 – 14.55
- Shares traded in the session
- 3,379,985
A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.
About the company
Ibnsina Pharma is a Cairo-based pharmaceutical company operating in the pharmaceuticals, biotechnology, and life sciences sector. Established in December 2000 and incorporated on 18 December 2000, it has been listed on the EGX since November 2017. Faisal Islamic Bank of Egypt holds 13.99%, alongside individual and institutional shareholders. The company owns a 99.99% stake in AIM for Investment and Consulting in Healthcare.
Its record at the exchange
Across 527 filings between 2017 and 2026, Ibnsina Pharma's busiest year was 2022 with 141 filings. Trading was suspended and resumed 3 times. Across 47 reported periods, the company recorded zero loss-making periods, with net profit ranging from 28 million EGP in Q1 2018 to a peak of 660 million EGP in 9M 2025. Filings include 86 board decisions, 81 assembly meetings, and 5 bonus share disclosures.
Its latest filings at the exchange
- Release from Ibnsina Pharma (ISPH.CA) Regarding the Purchase of Treasury Stocks
- Release from Ibnsina Pharma (ISPH.CA) Regarding the Purchase of Treasury Stocks
- Release from Ibnsina Pharma (ISPH.CA) Concerning the Purchase of Treasury Stocks
- Release from Ibnsina Pharma (ISPH.CA) Regarding the Purchase of Treasury Stocks
- Board decisionsRelease from Ibnsina Pharma (ISPH.CA) Concerning the BoD Meeting
- Release from Ibnsina Pharma (ISPH.CA) Regarding the Purchase of Treasury Stocks
- Release from Ibnsina Pharma (ISPH.CA) Regarding the Purchase of Treasury Stocks
- Release from Ibnsina Pharma (ISPH.CA) Regarding the Purchase of Treasury Stocks
Insider trades in the exchange’s bulletin
As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.
- Insider / Board Bought264,000 (0.03% of the company)Bulletin ↗
- Insider / Board Bought2,050 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought4,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought4,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought200,000 (0.02% of the company)Bulletin ↗
- Insider / Board Bought233,389 (0.02% of the company)Bulletin ↗
- Insider / Board Bought10,120 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought200,000 (0.02% of the company)Bulletin ↗
- Insider / Board Bought3,900 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought4,350 (less than 0.01% of the company)Bulletin ↗
Other companies in Health Care & Pharmaceuticals
- GlaxoSmithKline S.A.E. BIOC
- Cleopatra Hospital Company CLHO
- Egyptian International Pharmaceutical Industries Co. PHAR
- El-Nile Co. for Pharmaceuticals & Chemical Industries NIPH
- Alexandria New Medical Center Co. AMES
- Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda RMDA
- Minapharm Pharmaceuticals MIPH
- Kahira Pharmaceuticals & Chemical Industries Co. CPCI
- Memphis Pharmaceutical & Chemical Industries MPCI
- Alexandria Company for Pharmaceuticals and Chemical Industries AXPH
- Nozha International Hospital NINH
- October Pharma Co. OCPH
Page updated with the data of 15 Nov 2026.